CERo Therapeutics (CERO) 10-Q 12 May 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 12, 2023
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Fiscal Period Focus	Q1
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity Registrant Name	PHOENIX BIOTECH ACQUISITION CORP.
Entity Central Index Key	0001870404
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
City Area Code	215
Local Phone Number	731-9450
Entity File Number	001-40877
Entity Tax Identification Number	87-1088814
Entity Address, Address Line One	2201 Broadway, Suite 705
Entity Address, Postal Zip Code	94612
Entity Address, City or Town	Oakland
Entity Address, State or Province	CA
Entity Incorporation, State or Country Code	DE
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Common Class A [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	PBAX
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		2,173,298
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock
Trading Symbol	PBAXW
Security Exchange Name	NASDAQ
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
Trading Symbol	PBAXU
Security Exchange Name	NASDAQ
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		4,596,250

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash	$ 178,093	$ 475,870
Prepaid expenses and other assets	220,293	225,188
Marketable securities and cash held in Trust Account	14,031,783
Restricted cash held in Trust Account	0	41,665,974
TOTAL ASSETS	14,430,169	42,367,032
CURRENT LIABILITIES
Accounts payable and accrued expenses	2,017,184	1,653,120
Income tax payable	599,159	599,159
Shareholder redemption liability	0	27,842,747
Working capital loan - related party	650,000	650,000
Franchise tax Payable	23,531	0
Due to Affiliate	3,315	3,315
Total current liabilities	3,293,189	30,748,341
LONG TERM LIABILITIES
Deferred underwriting fee payable	9,150,000	9,150,000
Total liabilities	12,443,189	39,898,341
COMMITMENTS AND CONTINGENCIES
REDEEMABLE COMMON STOCK
Class A Common stock subject to possible redemption, $0.0001 par value, 1,288,298 shares at redemption value of $10.53 and $10.45 per share as of March 31, 2023 and December 31, 2022, respectively	13,565,640	13,468,845
STOCKHOLDER'S EQUITY
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(11,579,207)	(11,000,701)
Total stockholders' deficit	(11,578,660)	(11,000,154)
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS' DEFICIT	14,430,169	42,367,032
Common Class A [Member]
REDEEMABLE COMMON STOCK
Class A Common stock subject to possible redemption, $0.0001 par value, 1,288,298 shares at redemption value of $10.53 and $10.45 per share as of March 31, 2023 and December 31, 2022, respectively	13,565,640
STOCKHOLDER'S EQUITY
Common stock, value	88	88
Common Class B [Member]
STOCKHOLDER'S EQUITY
Common stock, value	$ 459	$ 459

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Temproary equity par or stated value per share	$ 0.0001	$ 0.0001
Temproary equity share authorized	1,288,298	1,288,298
Temproary equity redemption price per share	$ 10.53	$ 10.45
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Temproary equity share authorized	1,288,298
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	60,000,000	60,000,000
Common stock shares issued	885,000	885,000
Common stock shares outstanding	885,000	885,000
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	10,000,000	10,000,000
Common stock shares issued	4,596,250	4,596,250
Common stock shares outstanding	4,596,250	4,596,250

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
OPERATING EXPENSES
General and administrative	$ 566,568	$ 354,777
Franchise tax	23,700	50,000
Total operating expenses	590,268	404,777
OTHER INCOME (LOSS)
Interest income earned on marketable securities held in Trust Account	108,556	0
Unrealized gain on marketable securities held in Trust Account	0	26,780
Total other income	108,556	26,780
NET LOSS	(481,712)	(377,997)
Common Class A [Member]
OTHER INCOME (LOSS)
NET LOSS	$ (154,649)	$ (302,398)
Weighted Average Number of Shares Outstanding, Basic	2,173,298	18,385,000
Weighted Average Number of Shares Outstanding, Diluted	2,173,298	18,385,000
Earnings Per Share Basic	$ (0.07)	$ (0.02)
Earnings Per Share, Diluted	$ (0.07)	$ (0.02)
Common Class B [Member]
OTHER INCOME (LOSS)
NET LOSS	$ (327,063)	$ (75,599)
Weighted Average Number of Shares Outstanding, Basic	4,596,250	4,596,250
Weighted Average Number of Shares Outstanding, Diluted	4,596,250	4,596,250
Earnings Per Share Basic	$ (0.07)	$ (0.02)
Earnings Per Share, Diluted	$ (0.07)	$ (0.02)

Condensed Statements of Changes

Condensed Statements of Changes In Stockholders' Deficit - USD ($)	Total	Class A Common Stock [Member]	Class B Common Stock [Member]	Common Stock [Member] Class A Common Stock [Member]	Common Stock [Member] Class B Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Beginning Balance at Dec. 31, 2021	$ (7,669,865)			$ 88	$ 459	$ 0	$ (7,670,412)
Beginning Balance, Shares at Dec. 31, 2021				885,000	4,596,250
Net loss	(377,997)	$ (302,398)	$ (75,599)			0	(377,997)
Ending Balance, Shares at Mar. 31, 2022				885,000	4,596,250
Ending Balance at Mar. 31, 2022	(8,047,862)			$ 88	$ 459	0	(8,048,409)
Beginning Balance at Dec. 31, 2022	(11,000,154)			$ 88	$ 459	0	(11,000,701)
Beginning Balance, Shares at Dec. 31, 2022				885,000	4,596,250
Accretion for Class A Common Stock to redemption value	(96,794)					0	(96,794)
Net loss	(481,712)	$ (154,649)	$ (327,063)			0	(481,712)
Ending Balance, Shares at Mar. 31, 2023				885,000	4,596,250
Ending Balance at Mar. 31, 2023	$ (11,578,660)			$ 88	$ 459	$ 0	$ (11,579,207)

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (481,712)	$ (377,997)
Adjustments to reconcile net loss to net cash used in operating activities:
Unrealized gain on marketable securities held in Trust Account	0	(26,780)
Interest income earned on marketable securities held in Trust Account	(108,556)	0
Changes in operating assets and liabilities:
Prepaid expenses and other assets	4,896	20,101
Accounts payable and accrued expenses	364,064	106,909
Franchise tax Payable	23,531	(30,324)
Net cash flows used in operating activities	(197,777)	(308,091)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash deposited into Trust Account	(100,000)	0
Net cash used in for investing activities	(100,000)	0
NET CHANGE IN CASH	(297,777)	(308,091)
CASH, BEGINNING OF PERIOD	475,870	1,098,573
CASH, END OF PERIOD	178,093	790,482
Supplemental disclosure of noncash activities:
Accretion of Class A common stock subject to possible redemption	$ 96,794	$ 0

Description of Organization and

Description of Organization and Business Operations and Liquidity	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations and Liquidity	Note 1 – Description of Organization and Business Operations and Liquidity Phoenix Biotech Acquisition Corp. (the “Company”) was incorporated in Delaware on June 8, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2023, the Company had not commenced any operations. All activity through March 31, 2023, relates to the Company’s formation and initial public offering (“IPO”), which is described below and, since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating Simultaneously with the closing of the IPO, the Company consummated the sale of 845,000 units (“Private Placement Units”) (with respect to the Class A common stock included in the Private Placement Units offered, the “Private Placement Shares”) at a price of $10.00 per Private Placement Unit in a private placement to the Company’s sponsor, Phoenix Biotech Sponsor, LLC (the “Sponsor”), Cantor Fitzgerald & Co.(“Cantor”)and Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), generating gross proceeds of $8,450,000, which is described in Note 4. Simultaneously with the closing of the IPO, the Company consummated the sale of 2,000,000 additional Units upon receiving notice of the underwriter’s election to partially exercise its overallotment option (“Overallotment Units”), generating additional gross proceeds of $20,000,000 and incurring additional offering costs of $1,400,000 in underwriting fees, all of which are deferred until the completion of the Company’s initial Business Combination. Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional 40,000 Private Placement Units to the Sponsor and CCM, generating gross proceeds of $400,000. Offering costs for the IPO and exercise of the overallotment option amounted to $12,729,318, consisting of $2,635,000 of underwriting fees, $9,150,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $944,318 of other costs. As described in Note 6, the $9,150,000 of deferred underwriting fee payable is contingent upon the consummation of a Business Combination by July 8, 2023, subject to the terms of the underwriting agreement. Following the closing of the IPO, $178,500,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO, the Overallotment Units and the Private Placement Units was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in money market funds meeting the conditions of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.20 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights with respect to the Company’s warrants. All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in Accounting Standards Codification (“ASC”) 480-10-S99, 470-20. 480-10-S99. paid-in Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), Private Placement Shares and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A common stock sold in the IPO, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “Initial Stockholders”) have agreed not to propose an amendment to the Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (defined below), unless the Company provides the Public Stockholders with the opportunity to redeem their shares of Class A common stock in conjunction with any such amendment. On December 16, 2022, the Company held a special meeting of our stockholders (the “Special Meeting”). At the Special Meeting, our stockholders approved an amendment (the “IMTA Amendment”) to the Company’s Investment Management Trust Agreement (the “IMTA”), dated October 5, 2021, with Continental Stock Transfer & Trust Company (“CST”), as trustee, and an amendment to the Company’s Certificate of Incorporation, to extend the date by which we must consummate a business combination transaction by three months from January 8, 2023 to April 8, 2023, and provide our board of directors the ability to further extend the date by which we have to consummate a business combination up to three additional times for one month each time, for a maximum of six additional months (the “Charter Amendment”). As of the date of this report, the liquidation date of the Company has been extended to June 8, 2023. In connection with the Special Meeting, our sponsor agreed that if the Charter Amendment and the IMTA Amendment were approved at the Special Meeting, our sponsor, or one or more of its affiliates, members or third-party designees (in such capacity, the “Lender”), would lend to the Company up to $1,500,000 to be deposited into the T A IPO. into the Trust Account in connection with the first drawdown under the Promissory Note in order to effect the extension of the business combination period to June 8, 2023 and will deposit additional funds into the trust account for any subsequent extensions that are needed by the Company to complete an initial business combination. In T A If The The Risks and Uncertainties In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (“COVID-19”) COVID-19 COVID-19 Inflation Reduction Act of 2022 (the “IR Act”) On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. Liquidity and Going Concern As of March 31, 2023, the Company had $178,093 in its operating bank accounts, $14,031,783 in marketable securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its Public Shares in connection therewith and a working capital deficit of $2,295,644, excluding the effects of taxes payable. The Company currently projects that it will not have sufficient funds to cover its expenses over a one-year

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, Reclassifications Certain prior year amounts have been reclassified due to an immaterial correction of an error and for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations. An adjustment for $244,777 has been made to Class A common stock subject to possible redemption and Accumulated deficit as of December 31, 2022 to correct the total amount redeemable to shareholders. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2023 and December 31, 2022. Restricted Cash The Company considers all cash to be held for a specific purpose restricted cash. As of March 31, 2023 and December 31, 2022, the Company had $0 and $41,665,974 in restricted cash, respectively. The restricted cash as of December 31, 2022 was intended to satisfy shareholder redemption payments. The cash and restricted cash balances included in the balance sheets as of December 31, 2022 are comprised of the following: December 31, 2022 March 31, 2023 (Unaudited) Cash $ 475,870 $ 178,093 Restricted cash 41,665,974 — Total cash and restricted cash $ 42,141,844 $ 178,093 Investments Held in Trust Account At March 31, 2023, the assets held in Trust Account were held in U.S. Treasury securities. At December 31, 2022, substantially all of the assets held in the Trust Account were held as cash. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account and interest earned on marketable securities are included in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Shareholder Redemption Liability On December 20, 2022, in connection with the Company’s special meeting held to consider the Charter Amendment, the Company’s shareholders redeemed 16,211,702 shares of Class A common stock subject to possible redemption at $10.20 per share redemption value, plus a pro rata share of interest earned. Of the total amount redeemed, payments for true-up unaudited condensed Offering Costs associated with the Initial Public Offering Offering costs, including additional underwriting fees associated with the underwriter’s partial exercise of the over-allotment option, consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs, including those attributable to the underwriter’s partial exercise of the over-allotment option, amounted to $12,729,318. This amount was charged to stockholders’ deficit upon the completion of the IPO. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. At March 31, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. Income Taxes The Company complies with the accounting and reporting requirements of ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, 1,288,298 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. At March 31, 2023 and December 31, 2022, the Class A common stock subject to possible redemption reflected in the condensed balance sheets is reconciled in the following table: Class A common stock subject to possible redemption, December 31, 2022 $ 13,468,845 Plus: Accretion of carrying value to redemption value 96,795 Class A common stock subject to possible redemption, March 31, 2023 $ 13,565,640 Net Loss per Common Stock The Company has two classes of shares, which are referred to as Class A common stock and Class B Common Stock (the “Founder Shares”). Earnings and losses are shared pro rata between the two classes of shares. Public Warrants (see Note 3) and Private Placement Warrants (see Note 4) to purchase 9,192,500 shares of Class A common stock at $11.50 per share were issued on October 29, 2021. At March 31, 2023 and December 31, 2022, no Public Warrants or Private Placement Warrants have been exercised. The 9,192,500 potential shares of Class A common stock underlying outstanding Public Warrants and Private Placement Warrants to purchase the Company’s stock were excluded from diluted losses per share for the three months ended March 31, 2023 and 2022 because they are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of stock. For the Three Months Ended March 31, 2023 (Unaudited) For the Three Months Ended March 31, 2022 (Unaudited) Class A Common Class B Common Class A Common Class B Common Stock Stock Stock Stock Basic and diluted net loss per share: Numerator: Allocation of net loss $ (154,649 ) $ (327,063 ) $ (302,398 ) $ (75,599 ) Denominator: Weighted average shares outstanding 2,173,298 4,596,250 18,385,000 4,596,250 Basic and dilution net loss per share $ (0.07 ) $ (0.07 ) $ (0.02 ) $ (0.02 ) Accounting for Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2023
Disclosure Of Initial Public Offering [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering and Over-Allotment Pursuant to the IPO, the Company sold 17,500,000 units (including 2,000,000 units as part of the underwriter’s partial exercise of the over-allotment option) at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock (such shares of Class A common stock included in the Units being offered, the “Public Shares”), and one one

Private Placement Warrants

Private Placement Warrants	3 Months Ended
	Mar. 31, 2023
Private Placement [Abstract]
Private Placement Warrants	Note 4 — Private Placement Warrants On October 8, 2021, simultaneously with the consummation of the IPO, the Company consummated the issuance and sale (“Private Placement”) of 885,000 Units (the “Private Placement Units”) in a private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $8,850,000. The Private Placement Units were purchased by Cantor (155,000 Units), CCM (30,004 Units) and the Sponsor (699,996 Units). Each whole Private Placement Unit consists of one Private Placement Share and one

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On September 18, 2021, the Sponsor provided funds to pay for certain costs totaling $25,000 on behalf of the Company as consideration for 4,598,750 shares of Class B common stock (the “Founder Shares”). Later in 45-day The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of: (a) one year after the completion of a Business Combination and (b) subsequent to a Business Combination, (x) if the closing price of the shares of Class A common stock equals or exceeds $12.00 per share (as adjusted) for any 20 trading days within any 30-trading day Related Party Loans On June 18, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to a promissory note which was amended on September 10, 2021 (as amended, the “Note”). This loan is non-interest-bearing. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans will either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. On December 13, 2022, the Company entered into a promissory note with the Sponsor. In order to fund ongoing operations, the Sponsor will loan up to $1,500,000 to the Company. The Promissory Note does not bear interest and matures upon the earlier of (a) the closing of an initial business combination and (b) the Company’s liquidation. In the event that the Company does not consummate an initial business combination, the Promissory Note will be repaid only from amounts remaining outside of the trust account, if any. As of March 31, 2023 and December 31, 2022, there was $650,000 in borrowings under the Working Capital Loans. Consulting Services The Company entered into an agreement, commencing on the date of its listing on NASDAQ, to pay the spouse of our Chief Executive Officer a monthly consulting fee of $15,000 for assisting the Company in identifying and evaluating potential acquisition targets. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees. The payments ended on December 31, 2022 in connection with the approval of the Charter Amendment. For the three months ended March 31, 2023 and 2022 Support Services The Company entered into an agreement, commencing on the date of its listing on NASDAQ through the earlier of the consummation of a Business Combination and the Company’s liquidation, to pay an affiliate of the Sponsor a monthly fee of $20,000 for office space, secretarial and administrative services. Payments under the agreement were suspended on December 31, 2022 and reinstated on March 31, 2023. For the three months ended March 31, 2023 and 2022

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6 — Commitments and Contingencies Registration Rights Pursuant to a registration rights agreement entered into on October 5, 2021, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement, requiring the Company to register such securities and any other securities of the Company acquired by them prior to the consummation of a Business Combination for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriter a 45-day option The underwriter was paid a cash underwriting discount of $0.20 per unit, or $3,100,000 in the aggregate at the closing of the IPO, of which $465,000 was reimbursed to the Company to pay for additional advisors. The underwriter agreed to defer any additional fees related to the exercise of the over-allotment option until the Company completes a Business Combination. As such, $400,000 of additional underwriting fees related to the over-allotment have been deferred. In addition, the underwriter is entitled to deferred underwriting commissions of $0.50 per unit, or $8,750,000 ($9,150,000 in the aggregate when including the $400,000 noted above) from the closing of the IPO. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' Deficit	Note 7 — Stockholders’ Deficit Common Stock Class A common stock — The Company is authorized to issue 60,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of March 31, 2023 and December 31, 2022, there were 885,000 shares of Class A common stock issued and outstanding (excluding 1,288,298 shares subject to possible redemption). Class B common stock — The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of March 31, 2023 and December 31, 2022, there were 4,596,250 shares of Class B common stock issued and outstanding. Prior to the consummation of an initial Business Combination, only holders of shares of Class B common stock will have the right to vote on the election of directors. Holders of shares of Class A common stock and shares of Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of than one-to-one. Preferred stock Warrants — Notwithstanding the foregoing, if a registration statement covering the common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Once the warrants become exercisable, the Company may redeem the Public Warrants: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption; • if, and only if, the reported last sale price of Class A common stock equals or exceeds $ 18.00 20 a 30 • if, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying the warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the IPO, except that the Private Placement Warrants and the common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable, or salable until after the completion of a Business Combination, subject to certain limited exceptions. The Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. However, the warrants will not be adjusted for issuances of common stock at a price below their respective exercise prices, other than as set forth below. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Initial Stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), and (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted-average trading price of the Company’s common stock during the 20-trading-day period

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8 — Fair Value Measurements The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. At March 31, 2023, the assets held in the Trust Account were held in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. At December 31, 2022 there were no assets or liabilities measured at fair value. March 31, 2023 (Unaudited) Level Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: U.S. Treasury Securities 1 $ 14,031,783 — —

Uncertainty Regarding Impacts o

Uncertainty Regarding Impacts of Recent Disruptions in U.S. Banking System	3 Months Ended
	Mar. 31, 2023
Risks and Uncertainties [Abstract]
Uncertainty Regarding Impacts of Recent Disruptions in U.S. Banking System	Note 9 — Uncertainty Regarding Impacts of Recent Disruptions In U.S. Banking System In March 2023, the shut-down of certain financial institutions raised economic concerns over disruption in the U.S. banking system. The U.S. government took certain actions to strengthen public confidence in the U.S. banking system. However, there can be no certainty that the actions taken by the U.S. government will be effective in mitigating the effects of financial institution failures on the economy, which may include limits on access to short term liquidity in the near term or other adverse effects. As disclosed in Note 2, the Company maintains cash amounts in excess of federally insured limits in the aggregate amount of $42,141,844 as of December 31, 2022, and has certain concentrations in credit risk that expose the Company to risk of loss if the counterparty is unable to perform as a result of future disruptions in the U.S. banking system or economy. Given the uncertainty of the situation, the related financial impact cannot be reasonably estimated at this time.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review, other than below, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements. NASDAQ Notice On April 3, 2023, the Company received a letter (the “Letter”) from the staff at The Nasdaq Global Market (“Nasdaq”) notifying the Company that, for the 30 consecutive trading days prior to the date of the Letter, the Company’s common stock had traded at a value below the minimum $50,000,000 “Market Value of Listed Securities” (“MVLS”) requirement set forth in Nasdaq Listing Rule 5450(b)(2)(A), which is required for continued listing of the Company’s common stock on Nasdaq. The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq. In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar days, or until October 2, 2023, to regain compliance. The Letter notes that to regain compliance, the Company’s common stock must trade at or above a level such that the Company’s MVLS closes at or above $50,000,000 for a minimum of ten consecutive business days during the compliance period, which ends October 2, 2023. The Letter further notes that if the Company is unable to satisfy the MVLS requirement prior to such date, the Company may be eligible to transfer the listing of its securities to The Nasdaq Capital Market (provided that it then satisfies the requirements for continued listing on that market). If the Company does not regain compliance by October 2, 2023, Nasdaq staff will provide written notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel. The Company intends to actively monitor the Company’s MVLS between now and October 2, 2023, and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the MVLS requirement. While the Company is exercising diligent efforts to maintain the listing of its securities on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standard s. Working Capital Loans On May 5, 2023, the sponsor loaned the company $250,000 under the working capital loan program. The loan is subject to the same terms as the $650,000 working capital loaned during 2022. E xtension Payment On May 8 2023, the Company deposited $125,000 into the Trust Account in connection with the Company’s extension. Tax Payment On May 9, 2023, the Company received a notice from the IRS stating an additional $182,308 of federal income taxes are due by May 22, 2023. The Company intends on making this paymen t on or before June 30, 2023.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K,
Reclassifications	Reclassifications Certain prior year amounts have been reclassified due to an immaterial correction of an error and for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations. An adjustment for $244,777 has been made to Class A common stock subject to possible redemption and Accumulated deficit as of December 31, 2022 to correct the total amount redeemable to shareholders.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2023 and December 31, 2022.
Restricted Cash	Restricted Cash The Company considers all cash to be held for a specific purpose restricted cash. As of March 31, 2023 and December 31, 2022, the Company had $0 and $41,665,974 in restricted cash, respectively. The restricted cash as of December 31, 2022 was intended to satisfy shareholder redemption payments. The cash and restricted cash balances included in the balance sheets as of December 31, 2022 are comprised of the following: December 31, 2022 March 31, 2023 (Unaudited) Cash $ 475,870 $ 178,093 Restricted cash 41,665,974 — Total cash and restricted cash $ 42,141,844 $ 178,093
Investments Held in Trust Account	Investments Held in Trust Account At March 31, 2023, the assets held in Trust Account were held in U.S. Treasury securities. At December 31, 2022, substantially all of the assets held in the Trust Account were held as cash. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account and interest earned on marketable securities are included in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Shareholder Redemption Liability	Shareholder Redemption Liability On December 20, 2022, in connection with the Company’s special meeting held to consider the Charter Amendment, the Company’s shareholders redeemed 16,211,702 shares of Class A common stock subject to possible redemption at $10.20 per share redemption value, plus a pro rata share of interest earned. Of the total amount redeemed, payments for true-up unaudited condensed
Offering Costs associated with the Initial Public Offering	Offering Costs associated with the Initial Public Offering Offering costs, including additional underwriting fees associated with the underwriter’s partial exercise of the over-allotment option, consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs, including those attributable to the underwriter’s partial exercise of the over-allotment option, amounted to $12,729,318. This amount was charged to stockholders’ deficit upon the completion of the IPO.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. At March 31, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, 1,288,298 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. At March 31, 2023 and December 31, 2022, the Class A common stock subject to possible redemption reflected in the condensed balance sheets is reconciled in the following table: Class A common stock subject to possible redemption, December 31, 2022 $ 13,468,845 Plus: Accretion of carrying value to redemption value 96,795 Class A common stock subject to possible redemption, March 31, 2023 $ 13,565,640
Net Loss per Common Stock	Net Loss per Common Stock The Company has two classes of shares, which are referred to as Class A common stock and Class B Common Stock (the “Founder Shares”). Earnings and losses are shared pro rata between the two classes of shares. Public Warrants (see Note 3) and Private Placement Warrants (see Note 4) to purchase 9,192,500 shares of Class A common stock at $11.50 per share were issued on October 29, 2021. At March 31, 2023 and December 31, 2022, no Public Warrants or Private Placement Warrants have been exercised. The 9,192,500 potential shares of Class A common stock underlying outstanding Public Warrants and Private Placement Warrants to purchase the Company’s stock were excluded from diluted losses per share for the three months ended March 31, 2023 and 2022 because they are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of stock. For the Three Months Ended March 31, 2023 (Unaudited) For the Three Months Ended March 31, 2022 (Unaudited) Class A Common Class B Common Class A Common Class B Common Stock Stock Stock Stock Basic and diluted net loss per share: Numerator: Allocation of net loss $ (154,649 ) $ (327,063 ) $ (302,398 ) $ (75,599 ) Denominator: Weighted average shares outstanding 2,173,298 4,596,250 18,385,000 4,596,250 Basic and dilution net loss per share $ (0.07 ) $ (0.07 ) $ (0.02 ) $ (0.02 )
Accounting for Warrants	Accounting for Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of cash and restricted cash	The cash and restricted cash balances included in the balance sheets as of December 31, 2022 are comprised of the following: December 31, 2022 March 31, 2023 (Unaudited) Cash $ 475,870 $ 178,093 Restricted cash 41,665,974 — Total cash and restricted cash $ 42,141,844 $ 178,093
Summary of Reconciliation of cash flow from common stock subject to possible redemption to redemption value	At March 31, 2023 and December 31, 2022, the Class A common stock subject to possible redemption reflected in the condensed balance sheets is reconciled in the following table: Class A common stock subject to possible redemption, December 31, 2022 $ 13,468,845 Plus: Accretion of carrying value to redemption value 96,795 Class A common stock subject to possible redemption, March 31, 2023 $ 13,565,640
Summary of basic and diluted net income (loss) per common share	The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of stock. For the Three Months Ended March 31, 2023 (Unaudited) For the Three Months Ended March 31, 2022 (Unaudited) Class A Common Class B Common Class A Common Class B Common Stock Stock Stock Stock Basic and diluted net loss per share: Numerator: Allocation of net loss $ (154,649 ) $ (327,063 ) $ (302,398 ) $ (75,599 ) Denominator: Weighted average shares outstanding 2,173,298 4,596,250 18,385,000 4,596,250 Basic and dilution net loss per share $ (0.07 ) $ (0.07 ) $ (0.02 ) $ (0.02 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. At December 31, 2022 there were no assets or liabilities measured at fair value. March 31, 2023 (Unaudited) Level Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: U.S. Treasury Securities 1 $ 14,031,783 — —

Description of Organization a_2

Description of Organization and Business Operations and Liquidity - Additional Information (Detail) - USD ($)				3 Months Ended
	Jan. 03, 2023	Dec. 20, 2022	Oct. 08, 2021	Mar. 31, 2023	Dec. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Investment of cash in trust account			$ 178,500,000
Cash deposited in trust account per unit			$ 10.2
Term of restricted investments			185 days
Redemption value per share				$ 10.2
Minimum net worth to consummate business combination				$ 5,000,001
Expenses payable on dissolution				$ 100,000
Value per share to be maintained in the trust account				$ 10.2
Cash				$ 178,093	$ 475,870
Net working capital				2,295,644
Assets Held-in-trust, Current				$ 14,031,783
Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of shares redeemed	2,581,004	16,211,702		16,211,702
Number of temporary equity shares outstanding for redemptions				2,173,298
Public Shares issued				$ 88	$ 88
Unsecured promissory note [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Assets held in trust non current				$ 550,000
Business Combination [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Business acquisition, effective date of acquisition				Jun. 08, 2023
Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Fair market value as percentage of net assets held in trust account included in initial business combination				80%
Post-transaction ownership percentage of the target entity				50%
Initial Stockholders [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period				100%
Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Maximum borrowing capacity		$ 1,500,000		$ 1,500,000
Sponsor [Member] | Unsecured promissory note [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Unsecured promissory note		$ 1,500,000
IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Units issued during the period shares			15,500,000
Unit price per share			$ 10
Proceeds from initial public offering gross			$ 155,000,000
Offering costs			12,729,318
Underwriting fees			2,635,000
Deferred underwriting fees payable			9,150,000
Other offering costs			$ 944,318
Public Shares issued				$ 1,288,298
IPO [Member] | Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Units issued during the period shares			17,500,000
Unit price per share			$ 10
Private Placement [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Units issued during the period shares			885,000
Unit price per share			$ 10
Proceeds from issuance of private placement			$ 8,850,000
Private placement Units				885,000
Private Placement [Member] | Sponsor and Cohen and Company Capital Markets [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Units issued during the period shares			(699,996)
Additional units issued during the period shares			40,000
Proceeds from issuance of additional private placement units			$ 400,000
Private Placement [Member] | Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Units issued during the period shares			845,000
Unit price per share			$ 10
Proceeds from issuance of private placement			$ 8,450,000
Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Units issued during the period shares			2,000,000
Unit price per share			$ 10
Deferred underwriting fees payable			$ 1,400,000
Units issued during the period value			$ 20,000,000
Over-Allotment Option [Member] | Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Units issued during the period shares			2,000,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies -Additional Information (Details) - USD ($)				3 Months Ended	12 Months Ended
	Jan. 03, 2023	Dec. 20, 2022	Oct. 08, 2021	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Line Items]
Cash Equivalents				$ 0		$ 0
Cash, FDIC Insured amount				250,000
Unrecognized tax benefits				0		0
Unrecognized tax benefits income tax penalties and interest accrued				$ 0		$ 0
Temporary equity shares outstanding				1,288,298		1,288,298
Temporary Equity, Redemption Price Per Share				$ 10.53		$ 10.45
Shareholder redemption liability				$ 0		$ 27,842,747
Restricted Cash				$ 0		$ 41,665,974
Common Class A [Member]
Accounting Policies [Line Items]
Temporary equity shares outstanding				1,288,298		1,288,298
Number of shares redeemed	2,581,004	16,211,702		16,211,702
Temporary Equity, Redemption Price Per Share		$ 10.2
Stock Redeemed or Called During Period, Value	$ 26,481,101
Payments of Stock Issuance Costs	1,361,646
Shareholder redemption liability	$ 27,842,747
Common Class A [Member] | Revision of Prior Period, Reclassification, Adjustment [Member]
Accounting Policies [Line Items]
Adjustment for common stock subject to possible redemption and Accumulated deficit					$ 244,777
Public Warrants And Private Placement Warrants To Purchase Common Stock [Member]
Accounting Policies [Line Items]
Class of warrants or rights number of securities called for by the warrants or rights				9,192,500
Class of warrants or rights exercise price per unit				$ 11.5
Antidilutive securities excluded from the computation of earnings per share				9,192,500
Initial Public Offer And Overallotement [Member]
Accounting Policies [Line Items]
Offering Costs			$ 12,729,318

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Cash and Restricted Cash (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash	$ 178,093	$ 475,870
Restricted Cash	0	41,665,974
Total cash and restricted cash	$ 178,093	$ 42,141,844

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary of Reconciliation of Cash Flow from Common Stock Subject to Possible Redemption to Redemption Value (Detail) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Reconciliation of cash flow from common stock subject to possible redemption to redemption value
Class A common stock subject to possible redemption	$ 13,565,640	$ 13,468,845
Common Class A [Member]
Reconciliation of cash flow from common stock subject to possible redemption to redemption value
Class A common stock issuance costs	13,468,845
Accretion of carrying value to redemption value	96,795
Class A common stock subject to possible redemption	$ 13,565,640

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share) (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share Basic And Diluted [Line Items]
Allocation of net loss	$ (481,712)	$ (377,997)
Common Class A [Member]
Earnings Per Share Basic And Diluted [Line Items]
Allocation of net loss	$ (154,649)	$ (302,398)
Weighted Average Number of Shares Outstanding, Basic	2,173,298	18,385,000
Weighted Average Number of Shares Outstanding, Diluted	2,173,298	18,385,000
Earnings Per Share Basic	$ (0.07)	$ (0.02)
Earnings Per Share, Diluted	$ (0.07)	$ (0.02)
Common Class B [Member]
Earnings Per Share Basic And Diluted [Line Items]
Allocation of net loss	$ (327,063)	$ (75,599)
Weighted Average Number of Shares Outstanding, Basic	4,596,250	4,596,250
Weighted Average Number of Shares Outstanding, Diluted	4,596,250	4,596,250
Earnings Per Share Basic	$ (0.07)	$ (0.02)
Earnings Per Share, Diluted	$ (0.07)	$ (0.02)

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Details) - $ / shares	Oct. 08, 2021	Mar. 31, 2023	Dec. 31, 2022
Public Warrants [Member]
Class of Stock [Line Items]
Number of warrants included in Unit		1
IPO [Member]
Class of Stock [Line Items]
Units Issued During Period Shares New Issues	15,500,000
Shares Issued, Price Per Share	$ 10
Over-allotment option[Member]
Class of Stock [Line Items]
Units Issued During Period Shares New Issues	2,000,000
Shares Issued, Price Per Share	$ 10
Common Class A [Member]
Class of Stock [Line Items]
Number Of Shares Included In Unit		1
Common Class A [Member] | Public Warrants [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		1
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 11.5
Shares Issued, Price Per Share		$ 18
Common Class A [Member] | IPO [Member]
Class of Stock [Line Items]
Units Issued During Period Shares New Issues	17,500,000
Shares Issued, Price Per Share	$ 10
Common Class A [Member] | Over-allotment option[Member]
Class of Stock [Line Items]
Units Issued During Period Shares New Issues	2,000,000

Private Placement Warrants - Ad

Private Placement Warrants - Additional Information (Details) - USD ($)	Oct. 08, 2021	Mar. 31, 2023	Dec. 31, 2022
Common Class A [Member]
Class of Stock [Line Items]
Number Of Shares Included In Unit		1
Private Placement Warrants [Member] | Common Class A [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		1
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 11.5
Public Warrants [Member]
Class of Stock [Line Items]
Number of warrants included in Unit		1
Public Warrants [Member] | Common Class A [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		1
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 11.5
Shares Issued, Price Per Share		$ 18
Private Placement [Member]
Class of Stock [Line Items]
Units Issued During Period Shares New Issues	885,000
Shares Issued, Price Per Share	$ 10
Proceeds from Issuance of Private Placement	$ 8,850,000
Private Placement [Member] | Cantor Fitzgerald and Co [Member]
Class of Stock [Line Items]
Units Issued During Period Shares New Issues	(155,000)
Private Placement [Member] | Cohen and Company Capital Markets [Member]
Class of Stock [Line Items]
Units Issued During Period Shares New Issues	(30,004)
Private Placement [Member] | Sponsor and Cohen and Company Capital Markets [Member]
Class of Stock [Line Items]
Units Issued During Period Shares New Issues	(699,996)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)				3 Months Ended
	Oct. 08, 2021	Sep. 30, 2021	Jun. 18, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 13, 2022
Underwriter Agreement [Member]
Related Party Transaction [Line Items]
Option for underwriters to purchase additional units term				45 days
Sponsor [Member]
Related Party Transaction [Line Items]
Monthly consulting fee				$ 15,000
Consulting fee incurred under this agreement				0	$ 45,000
Sponsor [Member] | Working Capital Loans [Member]
Related Party Transaction [Line Items]
Debt instrument face value				$ 1,500,000
Debt instrument conversion price per share				$ 10
Related party transaction fees payable per month				$ 20,000
Sponsor [Member] | Administration And Support Services [Member]
Related Party Transaction [Line Items]
Cumulative Expenses Incurred				$ 20,000	$ 60,000
Sponsor [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument face value			$ 300,000			$ 650,000	$ 1,500,000
Common Class B [Member]
Related Party Transaction [Line Items]
Common stock shares outstanding				4,596,250		4,596,250
Common Class B [Member] | Underwriter Agreement [Member]
Related Party Transaction [Line Items]
Option for underwriters to purchase additional units term				45 days
Common Class B [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during the period for services value			$ 25,000
Stock issued during the period shares issued for services			4,598,750
Common stock shares outstanding				4,679,125
Common stock subject to forfeiture				592,875
Founder shares forfeited during the period	82,875
Common Class B [Member] | Sponsor [Member] | Recapitalization [Member]
Related Party Transaction [Line Items]
Common stock dividends per share		$ 0.017
Common Class A [Member]
Related Party Transaction [Line Items]
Common stock shares outstanding				885,000		885,000
Common Class A [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Share price				$ 12
Threshold trading days				20 days
Threshold consecutive trading days				30 days
Period after Initial Business Combination				150 days

Commitments and Contingencies -

Commitments and Contingencies - Additional information (Details) - USD ($)		3 Months Ended
	Oct. 08, 2021	Mar. 31, 2023
Over-Allotment Option [Member]
Commitments And Contingencies Disclosure [Line Items]
Shares Issued, Price Per Share	$ 10
Deferred Underwriting Fees Payable	$ 1,400,000
Units Issued During Period Shares New Issues	2,000,000
IPO [Member]
Commitments And Contingencies Disclosure [Line Items]
Shares Issued, Price Per Share	$ 10
Deferred Underwriting Fees Payable	$ 9,150,000
Units Issued During Period Shares New Issues	15,500,000
Underwriter Agreement [Member]
Commitments And Contingencies Disclosure [Line Items]
Option for underwriters to purchase additional units term		45 days
Additional Units That Can Be Purchased To Cover Over Allotments		2,325,000
Underwriter Agreement [Member] | Over-Allotment Option [Member]
Commitments And Contingencies Disclosure [Line Items]
Deferred Underwriting Fees Payable	$ 400,000
Underwriter Agreement [Member] | IPO [Member]
Commitments And Contingencies Disclosure [Line Items]
Underwriting Discount Per Unit	$ 0.2
Cash Underwriting Discount	$ 3,100,000
Reimbursement from Underwriters for Payment to Additional Parties	465,000
Deferred Underwriting Fees Payable	$ 8,750,000
Deferred Underwriting Commissions Per Unit	$ 0.5
Underwriter Agreement [Member] | Initial Public Offer And Overallotement [Member]
Commitments And Contingencies Disclosure [Line Items]
Deferred Underwriting Fees Payable	$ 9,150,000

Stockholders' Deficit - Additio

Stockholders' Deficit - Additional Information (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Preferred Stock Shares Authorized	1,000,000	1,000,000
Period to exercise warrants after business combination	30 days
Notice period to redeem warrants	30 days
Temporary equity shares outstanding	1,288,298	1,288,298
Public Warrants [Member]
Class of Warrant or Right, Outstanding	442,500	442,500
Private Placement Warrants [Member]
Class of Warrant or Right, Outstanding	8,750,000	8,750,000
Warrants And Rights Subject To Mandatory Redemption Trigger Price Exceeds Or Equals To Eighteen Dollars Per Share [Member] | Public Warrants [Member]
Class of warrant redemption price	$ 0.01
Threshold trading days	20 days
Threshold consecutive trading days	30 days
Common Class A [Member]
Common Stock Shares Authorized	60,000,000	60,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares issued	885,000	885,000
Common Stock Shares Outstanding	885,000	885,000
Temporary equity shares outstanding	1,288,298	1,288,298
Common Class A [Member] | Public Warrants [Member]
Shares Issued Price Per Share	$ 18
Percentage of Adjustment of Redemption Trigger Price	180%
Common Class A [Member] | Public Warrants [Member] | Event Triggering Adjustment To Exercise Price Of Warrants [Member]
Threshold trading days	20 days
Shares Issued Price Per Share	$ 9.2
Proceeds to be used for effecting business combination as a percentage of total proceeds	60%
Volume weighted average price per share	$ 9.2
Adjusted Exercise Price of Warrants Percentage	115%
Common Class A [Member] | Warrants And Rights Subject To Mandatory Redemption Trigger Price Exceeds Or Equals To Eighteen Dollars Per Share [Member] | Public Warrants [Member]
Share Price	$ 18
Common Class A [Member] | Sponsor [Member]
Share Price	$ 12
Threshold trading days	20 days
Threshold consecutive trading days	30 days
Common Class B [Member]
Common Stock Shares Authorized	10,000,000	10,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares issued	4,596,250	4,596,250
Common Stock Shares Outstanding	4,596,250	4,596,250
Common Class B [Member] | Sponsor [Member]
Common Stock Voting Rights	one vote
Common Stock Shares Outstanding	4,679,125
Percentage of common stock issued and outstanding	20%

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Company's Liabilities That are Measured at Fair Value on a Recurring Basis (Detail)	Mar. 31, 2023 USD ($)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
U.S. Treasury Securities	$ 14,031,783

Uncertainty Regarding Impacts_2

Uncertainty Regarding Impacts of Recent Disruptions in U.S. Banking System - Additional Information (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Concentration Risk [Line Items]
Cash, FDIC Insured Amount	$ 250,000
Credit Concentration Risk [Member]
Concentration Risk [Line Items]
Cash, FDIC Insured Amount		$ 42,141,844

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - USD ($)				3 Months Ended		12 Months Ended
	May 08, 2023	May 05, 2023	Apr. 03, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	May 09, 2023
Subsequent Event [Line Items]
Amount deposited into the Trust Account				$ 100,000	$ 0
Sponsor [Member] | Working Capital Loan Program [Member]
Subsequent Event [Line Items]
Proceeds from related party debt						$ 650,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Amount deposited into the Trust Account	$ 125,000
Minimum Common Stock Trade Level To Regain Compliance			$ 50,000,000
Number Of Consecutive Days For Which Minimum Market Value Of Listed Securities Must Exceed Prescribed Limit			30 days
Minimum Market Value Of Listed Securities			$ 50,000,000
Number Of Consecutive Days To Regain Compliance			180 days
Subsequent Event [Member] | Sponsor [Member] | Working Capital Loan Program [Member]
Subsequent Event [Line Items]
Proceeds from related party debt		$ 250,000
Subsequent Event [Member] | Internal Revenue Service (IRS) [Member]
Subsequent Event [Line Items]
Federal income taxes							$ 182,308